← The Wire
CRNXNasdaq
Crinetics Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1658247
Crinetics Pharmaceuticals discovers, develops, and commercializes novel therapies for endocrine diseases and tumors
red 8-K · 90d
$3.63B
Market cap
$36.94
Last close
+0.7%
1D
+4.4%
5D
884K
Volume
Price · last 39 sessions-10.4%
May 4L $32.61 · H $43.49Jun 29
201
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
10-K10-KFeb 26, 202610-K10-KFeb 27, 202510-K10-KFeb 28, 202410-K10-KFeb 28, 202310-K10-KMar 30, 202210-K10-KMar 30, 202110-K10-KMar 9, 202010-K10-KMar 13, 2019
Insider Activity
In the 90 days to Mar 16, 2026: 7 sold $2.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Struthers Richard ScottPresident & CEO | Sell | 13,196 | $37.11 | $490K |
| Mar 16, 2026 | Struthers Richard ScottPresident & CEO | Sell | 8,785 | $37.77 | $332K |
| Mar 16, 2026 | Betz Stephen F.Chief Scientific Officer | Sell | 6,371 | $37.11 | $236K |
| Mar 16, 2026 | Knight Jeff E.Chief Operating Officer | Sell | 5,950 | $37.11 | $221K |
| Mar 16, 2026 | Betz Stephen F.Chief Scientific Officer | Sell | 4,241 | $37.77 | $160K |
| Mar 16, 2026 | Knight Jeff E.Chief Operating Officer | Sell | 3,961 | $37.77 | $150K |
| Mar 12, 2026 | Vivaldi Coelho RogerioDirector | Sell | 4,477 | $36.08 | $162K |
| Mar 12, 2026 | Vivaldi Coelho RogerioDirector | Sell | 523 | $36.77 | $19K |
| Mar 3, 2026 | Schilke TobinChief Financial Officer | Sell | 6,713 | $39.67 | $266K |
| Mar 3, 2026 | Okey StephanieDirector | Sell | 3,000 | $39.67 | $119K |
| Jan 5, 2026 | Kalofonos IsabelChief Commercial Officer | Sell | 2,500 | $55.00 | $138K |
| Dec 1, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 5,000 | $45.02 | $225K |
| Nov 3, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 4,900 | $42.65 | $209K |
| Nov 3, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 100 | $43.27 | $4K |
| Oct 1, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 5,000 | $41.81 | $209K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance